- Global Pharma News & Resources

Global Infectious Disease Market to Grow by $62+ Billion During 2021-2025 - Strong Drug Pipeline is the Prime Catalyst -

DUBLIN--(BUSINESS WIRE)--The "Global Infectious Disease Market 2021-2025" report has been added to's offering.

The global infectious disease market is poised to grow by $62.83 billion during 2021-2025, accelerating at a CAGR of 10.19% during the forecast period.

This report provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.

The market is driven by the increasing prevalence of infectious diseases and growing awareness of infectious diseases. The study identifies the strong drug pipeline as one of the prime reasons driving the infectious disease market growth during the next few years.

The market is segmented as below:

By Product

  • Drugs
  • Vaccines

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • RoW

Key Companies Profiled

  • AbbVie Inc.
  • Boehringer Ingelheim International GmbH
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences Inc.
  • GlaxoSmithKline PLC
  • Johnson and Johnson Inc.
  • Merck and Co. Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.

For more information about this report visit

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 07-Jan-2022